Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Hematology
•
Sickle Cell
•
Benign Hematology
How do you acutely manage bleeding sites of extramedullary hematopoiesis in a patient with transfusion-dependent beta thalassemia?
Related Questions
Is there any indication for hydroxyurea in patients with sickle cell trait?
What would your next line of treatment be for a patient with Hb SC with history of recurrent VOC and new bone infarct who is already on hydroxyurea and phlebotomy?
How do you manage hyperalgesia in patients with sickle cell disease?
What subset of sickle cell disease patients are you offering sickle cell disease gene therapy?
Do you consider starting hydroxyurea in a patient with hemoglobin S-beta thalassemia with chronic kidney disease secondary to FSGS?
How would you manage a chronic thrombosis of the internal jugular vein?
Do you screen children with sickle cell disease for silent cerebral infarcts?
At what level and situation would you give antithrombin to a patient with acquired deficiency and heparin resistance?
What additional testing is recommended with heterozygous HFE C282Y mutation whose ferritin is elevated and transferrin saturation percentage is at baseline?
How do you manage mild Type 1 von Willebrand disease undergoing wisdom teeth removal?
